A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease
The DOI matches its Crossref record; 78 of the 87 references it cites were found in a registry or an index.
Abstract
A growing body of evidence from preclinical, translational, and clinical studies supports a bidirectional relationship within the gut-brain axis that contributes to neurobiological symptoms including anxiety, depression, fatigue, stress, and sleep disturbance. These symptoms have a significant impact on health-related quality of life and functional ability in individuals with inflammatory bowel disease. Clinical studies that generate high-quality evidence on pharmacological and nonpharmacological (eg, psychosocial, behavioral) interventions are needed to ultimately improve access to safe and effective therapies that have a meaningful impact on patients and to guide medical and regulatory decisions. This review outlines a framework for designing and conducting randomized controlled trials for interventions that target neurobiological symptoms in patients with inflammatory bowel disease based on the most recent guidance published within the past 5 years from policy makers, clinicians specialized in inflammatory bowel disease, patient-reported outcomes methodologists, health economists, patient advocates, industry representatives, ethicists, and clinical trial experts. © 2021 Crohn's & Colitis Foundation. Published by Oxford University Press. All rights reserved.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Smets, E. M. A., Garssen, B., Bonke, B., & De Haes, J. C. J. M. (1995) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)00125-o · Cited by 3,613
Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007) · Medical Care · doi:10.1097/01.mlr.0000258615.42478.55 · Cited by 3,118
Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.031 · Cited by 2,911
Self-citationMcCambridge, J., Witton, J., & Elbourne, D. R. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.08.015 · Cited by 2,748
(2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-79 · Cited by 1,506
Yu, L., Buysse, D. J., Germain, A., Moul, D. E., Stover, A., Dodds, N. E., Johnston, K. L., & Pilkonis, P. A. (2012) · Behavioral Sleep Medicine · doi:10.1080/15402002.2012.636266 · Cited by 1,241
International Ethical Guidelines for Health-related Research involving Humans
Council for International Organizations of Medical Sciences (CIOMS) (2016) · doi:10.56759/rgxl7405 · Cited by 878
Buysse, D. J., Hall, M. L., Strollo, P. J., Kamarck, T. W., Owens, J., Lee, L., Reis, S. E., & Matthews, K. A. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27351 · Cited by 858
Calvert, M., Kyte, D., Mercieca-Bebber, R., Slade, A., Chan, A.-W., King, M. T., and the SPIRIT-PRO Group, Hunn, A., Bottomley, A., Regnault, A., et al. (2018) · JAMA · doi:10.1001/jama.2017.21903 · Cited by 814
Minimal Clinically Important Difference: Defining What Really Matters to Patients
McGlothlin, A. E., & Lewis, R. J. (2014) · JAMA · doi:10.1001/jama.2014.13128 · Cited by 703
Bercik, P., Verdu, E. F., Foster, J. A., Macri, J., Potter, M., Huang, X., Malinowski, P., Jackson, W., Blennerhassett, P., Neufeld, K. A., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.063 · Cited by 674
Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000620 · Cited by 567
Depression and anxiety in patients with Inflammatory Bowel Disease: a systematic review
Neuendorf, R., Harding, A., Stello, N., Hanes, D., & Wahbeh, H. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.06.001 · Cited by 561
Mouelhi, Y., Jouve, E., Castelli, C., & Gentile, S. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01344-w · Cited by 450
Bi-directionality of brain–gut interactions in patients with inflammatory bowel disease
Gracie, D. J., Guthrie, E. A., Hamlin, P. J., & Ford, A. C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.027 · Cited by 408
Gracie, D. J., Hamlin, P. J., & Ford, A. C. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30089-5 · Cited by 354
Mikocka-Walus, A., Pittet, V., Rossel, J.-B., von Känel, R., Anderegg, C., Bauerfeind, P., Beglinger, C., Begré, S., Belli, D., Bengoa, J. M., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.045 · Cited by 348
Exploratory randomized controlled trial evaluating the impact of a waiting list control design
Cunningham, J. A., Kypri, K., & McCambridge, J. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-150 · Cited by 321
Graff, L. A., Walker, J. R., Lix, L., Clara, I., Rawsthorne, P., Rogala, L., Miller, N., Jakul, L., McPhail, C., Ediger, J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.027 · Cited by 292
Fatigue in IBD: epidemiology, pathophysiology and management
Borren, N. Z., van der Woude, C. J., & Ananthakrishnan, A. N. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0091-9 · Cited by 272
Gracie, D. J., Irvine, A. J., Sood, R., Mikocka-Walus, A., Hamlin, P. J., & Ford, A. C. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30206-0 · Cited by 271
Sleep Disturbance and Risk of Active Disease in Patients With Crohn's Disease and Ulcerative Colitis
Ananthakrishnan, A. N., Long, M. D., Martin, C. F., Sandler, R. S., & Kappelman, M. D. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.01.021 · Cited by 259
Frolkis, A. D., Vallerand, I. A., Shaheen, A.-A., Lowerison, M. W., Swain, M. G., Barnabe, C., Patten, S. B., & Kaplan, G. G. (2019) · Gut · doi:10.1136/gutjnl-2018-317182 · Cited by 228
Wynne, B., McHugh, L., Gao, W., Keegan, D., Byrne, K., Rowan, C., Hartery, K., Kirschbaum, C., Doherty, G., Cullen, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.030 · Cited by 188
Abautret-Daly, Á., Dempsey, E., Parra-Blanco, A., Medina, C., & Harkin, A. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.3 · Cited by 180
Kappelman, M. D., Long, M. D., Martin, C., DeWalt, D. A., Kinneer, P. M., Chen, W., Lewis, J. D., & Sandler, R. S. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.10.019 · Cited by 178
Gracie, D. J., Williams, C. J. M., Sood, R., Mumtaz, S., Bholah, H. M., Hamlin, J. P., & Ford, A. C. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.59 · Cited by 173
Targownik, L. E., Sexton, K. A., Bernstein, M. T., Beatie, B., Sargent, M., Walker, J. R., & Graff, L. A. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.147 · Cited by 157
Moradkhani, A., Beckman, L. J., & Tabibian, J. H. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.07.012 · Cited by 156
Ananthakrishnan, A. N., Khalili, H., Pan, A., Higuchi, L. M., de Silva, P., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.032 · Cited by 155
Tinsley, A., Macklin, E. A., Korzenik, J. R., & Sands, B. E. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04871.x · Cited by 147
Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A., Lix, L. M., Hitchon, C. A., El-Gabalawy, R., et al. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000579 · Cited by 144
Jedel, S., Hoffman, A., Merriman, P., Swanson, B., Voigt, R., Rajan, K. B., Shaikh, M., Li, H., & Keshavarzian, A. (2014) · Digestion · doi:10.1159/000356316 · Cited by 143
Ali, T., Madhoun, M. F., Orr, W. C., & Rubin, D. T. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182a0ea54 · Cited by 142
Czuber-Dochan, W., Norton, C., Bassett, P., Berliner, S., Bredin, F., Darvell, M., Forbes, A., Gay, M., Nathan, I., Ream, E., et al. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.04.013 · Cited by 139
Antidepressants Attenuate Increased Susceptibility to Colitis in a Murine Model of Depression
Varghese, A. K., Verdu, E. F., Berčík, P., Khan, W. I., Blennerhassett, P. A., Szechtman, H., & Collins, S. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.007 · Cited by 134
Fundamentals of clinical trial design
Evans, S. R. (2010) · Journal of Experimental Stroke and Translational Medicine · doi:10.6030/1939-067x-3.1.19 · Cited by 119
Bernstein, C. N., Zhang, L., Lix, L. M., Graff, L. A., Walker, J. R., Fisk, J. D., Patten, S. B., Hitchon, C. A., Bolton, J. M., Sareen, J., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy068 · Cited by 119
Boye, B., Lundin, K. E. A., Jantschek, G., Leganger, S., Mokleby, K., Tangen, T., Jantschek, I., Pripp, A. H., Wojniusz, S., Dahlstroem, A., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21575 · Cited by 113
The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases
Peppas, S., Pansieri, C., Piovani, D., Danese, S., Peyrin-Biroulet, L., Tsantes, A. G., Brunetta, E., Tsantes, A. E., & Bonovas, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030377 · Cited by 112
Essential considerations in developing attention control groups in behavioral research
Aycock, D. M., Hayat, M. J., Helvig, A., Dunbar, S. B., & Clark, P. C. (2018) · Research in Nursing & Health · doi:10.1002/nur.21870 · Cited by 110
Kinnucan, J. A. R., Rubin, D. T., & Ali, T. (2013) · Europe PMC (PubMed Central) · Cited by 110
Psychotherapy for inflammatory bowel disease: a review and update
McCombie, A. M., Mulder, R. T., & Gearry, R. B. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.02.004 · Cited by 105
Interventions for fatigue in inflammatory bowel disease
Farrell, D., Artom, M., Czuber-Dochan, W., Jelsness-Jørgensen, L. P., Norton, C., & Savage, E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012005.pub2 · Cited by 89
Bennebroek Evertsz', F., Sprangers, M. A. G., Sitnikova, K., Stokkers, P. C. F., Ponsioen, C. Y., Bartelsman, J. F. W. M., van Bodegraven, A. A., Fischer, S., Depla, A. C. T. M., Mallant, R. C., et al. (2017) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000227 · Cited by 84
Clock Gene Disruption Is an Initial Manifestation of Inflammatory Bowel Diseases
Weintraub, Y., Cohen, S., Chapnik, N., Ben‐Tov, A., Yerushalmy‐Feler, A., Dotan, I., Tauman, R., & Froy, O. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.013 · Cited by 83
Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship
Qazi, T., & Farraye, F. A. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy334 · Cited by 73
Collins, S. M. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa004 · Cited by 61
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease
Mikocka-Walus, A., Prady, S. L., Pollok, J., Esterman, A. J., Gordon, A. L., Knowles, S., & Andrews, J. M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012680.pub2 · Cited by 59
Goren, G., Schwartz, D., Friger, M., Banai, H., Sergienko, R., Regev, S., Abu-Kaf, H., Greenberg, D., Nemirovsky, A., Ilan, K., et al. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab083 · Cited by 56
Mental Health Costs of Inflammatory Bowel Diseases
Szigethy, E., Murphy, S. M., Ehrlich, O. G., Engel-Nitz, N. M., Heller, C. A., Henrichsen, K., Lawton, R., Meadows, P., & Allen, J. I. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa030 · Cited by 55
Hashash, J. G., Ramos-Rivers, C., Youk, A., Chiu, W. K., Duff, K., Regueiro, M., Binion, D. G., Koutroubakis, I., Vachon, A., Benhayon, D., et al. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000729 · Cited by 53
Intrinsic neural network dysfunction in quiescent Crohn’s Disease
Thomann, A. K., Griebe, M., Thomann, P. A., Hirjak, D., Ebert, M. P., Szabo, K., Reindl, W., & Wolf, R. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-11792-y · Cited by 51
Sofia, M. A., Lipowska, A. M., Zmeter, N., Perez, E. Y., Kavitt, R. T., & Rubin, D. T. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz258 · Cited by 51
Artom, M., Czuber-Dochan, W., Sturt, J., Proudfoot, H., Roberts, D., & Norton, C. (2019) · Pilot and Feasibility Studies · doi:10.1186/s40814-019-0538-y · Cited by 48
Thomann, A., Mak, J. W. Y., Zhang, J., Wüstenberg, T., Ebert, M. P., Sung, J. J. �., Bernstein, C. N., Reindl, W., & Ng, S. C. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15787 · Cited by 47
Self-reported sleep disturbance in Crohn’s disease is not confirmed by objective sleep measures
Iskandar, H. N., Linan, E. E., Patel, A., Moore, R., Lasanajak, Y., Gyawali, C. P., Sayuk, G. S., & Ciorba, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-58807-9 · Cited by 46
Hashash, J. G., Knisely, M. R., Germain, A., McAuliff, K., Strassburger, M., Vachon, A., Binion, D. G., Regueiro, M., Wallace, M., & Szigethy, E. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.09.047 · Cited by 37
Inflammatory Bowel Disease Patient Experiences with Psychotherapy in the Community
Craven, M. R., Quinton, S., & Taft, T. H. (2019) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-018-9576-5 · Cited by 35
Amara, J., Saliba, Y., Hajal, J., Smayra, V., Bakhos, J., Sayegh, R., & Farès, N. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05675-7 · Cited by 34
Davis, S. P., Bolin, L. P., Crane, P. B., & Crandell, J. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.538741 · Cited by 32
Shi, Q., Mendoza, T. R., & Cleeland, C. S. (2019) · Medical Care · doi:10.1097/mlr.0000000000001062 · Cited by 30
Horta, D., Lira, A., Sanchez-Lloansí, M., Villòria, A., Tegiacchi, M., Garcia-Rojo, D., García-Molina, S., Figuerola, A., Esteve, M., & Calvet, X. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz091 · Cited by 29
O’Connor, A., Ratnakumaran, R., Warren, L., Pullen, D., Errington, A., Gracie, D. J., Sagar, R. C., Hamlin, P. J., & Ford, A. C. (2019) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622319838439 · Cited by 25
Paixão, D. L., Poyares, D. R., de Paula, M. S., Duarte, J. W., Castelo, P. M., Ambrogini, O., Miszputen, S. J., Oshima, C. T. F., Chagas, J. R., & PAIOTTI, A. P. R. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7566 · Cited by 21
Psychological Comorbidity and Intervention in Inflammatory Bowel Disease
Kredentser, M. S., Graff, L. A., & Bernstein, C. N. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001463 · Cited by 19
Long, M. D., Martin, C. F., Chen, W., & Luo, M. (2019) · Crohn s & Colitis 360 · doi:10.1093/crocol/otz020 · Cited by 6
Placebo Arm as Part of Clinical Trial Design
Brody, T. (2016) · Clinical Trials · doi:10.1016/b978-0-12-804217-5.00007-2 · Cited by 2
Panaccione, R., Colombel, J. F., Bossuyt, P. J., Baert, F., Vaňásek, T., Danalıoğlu, A., Novacek, G., Armuzzi, A., Reinisch, W., Neimark, E., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx180.108 · Cited by 2
Research works printed but not linked: 17
- U.S. Food & Drug Administration., 2021, Code of Federal Regulations Title 21
- U.S. Food & Drug Administration., 2019, E8(R1) General considerations for clinical studies
- U.S. Food & Drug Administration., 2016, BEST (Biomarkers, EndpointS, and other Tools) Resource.
- European, 1998, ICH E8 General considerations for clinical trials
- U.S. Food & Drug Administration., DDT COA #000015: PROMIS® Short Form Fatigue 10a in Rheumatoid Arthritis
- U.S. Food & Drug Administration., 2017, Multiple endpoints in clinical trials guidance for industry.
- U.S. Food & Drug Administration., 2018, methods to identify what is important to patients and select, develop or modify fit-for-purpose clinical outcomes assessments
- U.S. Food & Drug Administration., 2019, incorporating clinical outcome assessments into endpoints for regulatory decision making
- U.S., 2020, Principles for selecting, developing, modifying, and adapting patient-reported outcome instruments for use in medical device evaluation
- U.S. Food & Drug Administration., 2018, Patient-focused drug development: collecting comprehensive and representative input
- Campbell, 2013, FDA guidance: design considerations for pivotal clinical investigations for medical devices
- Canadian Agency for Drugs and Technologies in Health., 2016, Entyvio (vedolizumab). Appendix 5: validity of outcome measures
- HealthMeasures., 2021, PROMIS® Score Cut Points
- Slagle, 2015, A Regulatory Perspective on Disease-Specific Outcome Measures: How does PROMIS Fit?
- Cohen, 1988, Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, eds, The social psychology of health. Sage Publications, Inc.;, 31
- Spielberger, 1989, State-Trait Anxiety Inventory: A Comprehensive Bibliography.
- Beck, 1996, Manual for the Beck Depression Inventory–II., San Antonio, TX: Psychological Corporation
Cited by
Jha, M., Waheed, A., Hooti, J. A., Nair, S., Najam, A., Mal, M. M., Tummala, N., Shariq, A. S., Hurairah, A., & Daniel, M. G. (2025) · Health Science Reports · doi:10.1002/hsr2.71157 · Cited by 11
Su, X.-Y., Wang, Y.-N., Huang, Y., & Dai, C. (2025) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2025.11305/2025 · Cited by 3
Stoikevych, M. V., Nedzvetskaya, N. V., & Tarasova, T. S. (2026) · GASTROENTEROLOGY · doi:10.22141/2308-2097.60.3.2026.736
Metadata
- Authors
- Tse, C. S., Singh, S., & Sandborn, W. J.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Sandborn, William J
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-07-09
- Volume
- 28
- Issue
- 5
- Pages
- 788-800
- ISSN
- 1078-0998 (ISSN-L)
- 1536-4844
- OpenAlex
- W3181381795
- Semantic Scholar
- 2da748fc1e0c134dc49f928c4fc57f77dd474080
- Cited by
- 3
- References
- 87
- Citations by year
- 2026: 1 · 2025: 2
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Keywords
- gut-brain axis, inflammatory bowel disease
- MeSH terms
- Brain-Gut Axis, Anxiety, Chronic Disease, Depression, Humans, Quality of Life, Sleep Wake Disorders, Inflammatory Bowel Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.